Honest Intake Answers Only: Why Gaming the Questionnaire Backfires Medically

The Medical Case for Honesty

This isn't a morality lecture. This is a clinical safety argument. GLP-1 intake questionnaires ask the questions they ask because the answers determine whether the medication is safe for you — and if it is, how it should be dosed and monitored.

When you misreport your weight, omit a medical condition, or deny a family history, you're not gaming a bureaucratic hurdle. You're removing data points that your prescriber uses to protect your health. The consequences aren't hypothetical — they're well-documented in adverse event reports.

Specific Risks of Specific Omissions

Omitting thyroid history: If you have undiagnosed thyroid nodules or a family history of MTC, GLP-1 therapy may increase your risk of thyroid tumors. This is the boxed warning on every GLP-1 medication. Your prescriber can't monitor what they don't know about.

Hiding an eating disorder history: GLP-1s cause significant appetite suppression. For someone with a history of anorexia or restrictive eating, this suppression can trigger a relapse. A prescriber who knows your history can implement safeguards — closer monitoring, nutritional support, mental health check-ins. A prescriber who doesn't know can't.

Understating current medications: GLP-1s interact with insulin, sulfonylureas, and other diabetes medications — potentially causing dangerous hypoglycemia. They also affect absorption timing for thyroid medications, blood thinners, and cardiac drugs. If your prescriber doesn't know your full medication list, they can't screen for interactions.

Overstating your weight: If you report a higher weight than your actual weight to meet BMI requirements, the resulting dose may be based on assumptions about your body mass that aren't accurate. Dosing conversations, particularly around titration speed, sometimes factor in body weight.

What If Honest Answers Get You Denied?

If your honest answers result in a denial, that denial may be protecting you. A condition that disqualifies you from one telehealth platform's automated intake may be manageable under closer clinical supervision. Instead of finding a platform that doesn't ask the disqualifying question, find a provider who can manage your treatment with the additional complexity in mind.

An endocrinologist or obesity medicine specialist can often prescribe GLP-1s for patients with comorbidities that trigger automatic denials on telehealth platforms. The specialist can provide the closer monitoring and clinical oversight that your specific situation requires.

When the Platform Asks Too Little

The flip side of the honesty question: what if the telehealth platform doesn't ask enough? The Yale JAMA study found that 67% of online GLP-1 vendors required no clinician interaction at all. Some platforms approved prescriptions based solely on a brief questionnaire that didn't include thyroid screening, eating disorder assessment, or medication interaction checks.

If a platform's intake process seems too easy — if it doesn't ask about the things discussed above — that's a red flag. You're not getting a less bureaucratic experience. You're getting a less thorough medical evaluation. The questions that seem like hurdles are actually safety infrastructure, and a platform that skips them is trading your safety for speed and volume.